Anti-CRISPR (Acr) proteins are natural inhibitors of CRISPR-Cas systems, the adaptive immune defenses used by bacteria to protect against invading viruses such as bacteriophages. These proteins are typically encoded by mobile genetic elements, including plasmids and phages, and serve as viral countermeasures by interfering with different stages of CRISPR-Cas activity. By blocking DNA recognition, cleavage, or complex assembly, Acrs effectively disarm bacterial defenses and provide viruses with an opportunity to infect and replicate. This interplay illustrates the ongoing evolutionary arms race between phages and their bacterial hosts, with each side continually adapting new strategies for survival.
Beyond their role in microbial ecology, Acr proteins have become powerful tools in biotechnology and medicine. By selectively modulating CRISPR activity, they help minimize off-target effects, refine gene editing outcomes, and improve the safety of CRISPR-based research and therapeutic applications. Their ability to fine-tune CRISPR activity makes Acrs essential components in developing next-generation genome engineering technologies.
More Reading:
Computational design of serine hydrolases
SHARE
